Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russ B Altman

Showing results (321-330 of 420) with videos related to

Pageof 42
Sort By:
Pharmacogenetics and Genomics|July 9, 2011
PharmGKB summary: carbamazepine pathwayCaroline F Thorn, Susan G Leckband, John Kelsoe, et al.
Nucleic Acids Research|December 26, 2001
PharmGKB: the Pharmacogenetics Knowledge BaseMicheal Hewett, Diane E Oliver, Daniel L Rubin, et al.
Pharmacogenetics and Genomics|May 2, 2012
PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6Ellen M McDonagh, Catherine Wassenaar, Sean P David, et al.
Nature Communications|September 22, 2021
Leveraging the Cell Ontology to classify unseen cell typesSheng Wang, Angela Oliveira Pisco, Aaron McGeever, et al.
Clinical Pharmacology and Therapeutics|September 29, 2019
Examining the Use of Real-World Evidence in the Regulatory ProcessBrett K Beaulieu-Jones, Samuel G Finlayson, William Yuan, et al.
Pharmacogenetics and Genomics|October 27, 2011
PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19Stuart A Scott, Katrin Sangkuhl, Alan R Shuldiner, et al.
Pharmacogenetics and Genomics|December 16, 2014
PharmGKB summary: ibuprofen pathwaysLiudmila L Mazaleuskaya, Katherine N Theken, Li Gong, et al.
Pharmacogenetics and Genomics|March 11, 2010
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Laura M Hodges, Svetlana M Markova, Leslie W Chinn, et al.
Plos One|March 1, 2018
Reversals and limitations on high-intensity, life-sustaining treatmentsGustavo Chavez, Ilana B Richman, Rajani Kaimal, et al.
Pharmacogenetics and Genomics|August 28, 2014
PharmGKB summary: gemcitabine pathwayMaria L Alvarellos, Jatinder Lamba, Katrin Sangkuhl, et al.
Pageof 42

Showing results (321-330 of 420) with videos related to

Sort By:
Pageof 42
Pharmacogenetics and Genomics|July 9, 2011
PharmGKB summary: carbamazepine pathwayCaroline F Thorn, Susan G Leckband, John Kelsoe, et al.
Nucleic Acids Research|December 26, 2001
PharmGKB: the Pharmacogenetics Knowledge BaseMicheal Hewett, Diane E Oliver, Daniel L Rubin, et al.
Pharmacogenetics and Genomics|May 2, 2012
PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6Ellen M McDonagh, Catherine Wassenaar, Sean P David, et al.
Nature Communications|September 22, 2021
Leveraging the Cell Ontology to classify unseen cell typesSheng Wang, Angela Oliveira Pisco, Aaron McGeever, et al.
Clinical Pharmacology and Therapeutics|September 29, 2019
Examining the Use of Real-World Evidence in the Regulatory ProcessBrett K Beaulieu-Jones, Samuel G Finlayson, William Yuan, et al.
Pharmacogenetics and Genomics|October 27, 2011
PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19Stuart A Scott, Katrin Sangkuhl, Alan R Shuldiner, et al.
Pharmacogenetics and Genomics|December 16, 2014
PharmGKB summary: ibuprofen pathwaysLiudmila L Mazaleuskaya, Katherine N Theken, Li Gong, et al.
Pharmacogenetics and Genomics|March 11, 2010
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Laura M Hodges, Svetlana M Markova, Leslie W Chinn, et al.
Plos One|March 1, 2018
Reversals and limitations on high-intensity, life-sustaining treatmentsGustavo Chavez, Ilana B Richman, Rajani Kaimal, et al.
Pharmacogenetics and Genomics|August 28, 2014
PharmGKB summary: gemcitabine pathwayMaria L Alvarellos, Jatinder Lamba, Katrin Sangkuhl, et al.
Pageof 42